‘Off the scale’ antibodies from Pfizer jab could protect against Brazil variant

Researchers have hailed the immune response of the Pfizer coronavirus vaccine (PA)

The Pfizer vaccine produces an “off the scale” immune response that is likely to protect against the Brazilian variant of Covid-19, researchers say.

The biggest study on antibody and cellular immune factors to date suggests people are likely to be protected against the Wuhan, Kent and Brazilian types of coronavirus following two doses of the vaccine.